Previously, we reported that aberrant activation of STAT3, but not AKT or extracellular signal–regulated kinase (ERK), mediated the IL-6-induced upregulation of FRA1, required for EMT activation and increased CRC aggressiveness [3]. The gene discussed is AKT1; the disease is colorectal carcinoma.